Epigenomics 2020

5 papers
Epigenomics in 2020 featured research focused on the identification of epigenetic biomarkers and the molecular mechanisms underlying various diseases. A primary area of study involved cancer progression, including investigations into long noncoding RNAs in esophageal squamous cell carcinoma and the dynamics of cell-free DNA methylomes in metastatic prostate cancer during androgen-targeting treatment. Researchers also examined the transcriptomic hallmarks of Helicobacter pylori infection in relation to gastric cancer and MALT lymphoma. Beyond oncology, the year’s contributions addressed metabolic and systemic conditions. Research included a methylome-wide association study linking central adiposity to genes within the immune and endocrine systems, as well as an analysis of m6A methylation spectroscopy during the progression of hepatic fibrosis. Prolific contributors to the venue during this period included authors such as Bin Chen, Duo Zheng, Feng Chen, and Li Fu. The collective work emphasized the application of sequencing and methylation analysis to understand disease dynamics and potential diagnostic indicators.

Top Authors

AuthorPapers
Gary D. Bader1

Papers

Title
Dynamic Analysis of m6A Methylation Spectroscopy During Progression and Reversal of Hepatic Fibrosis
Dynamics of the Cell-Free DNA Methylome of Metastatic Prostate Cancer During Androgen-Targeting Treatment
Methylome-Wide Association Study of Central Adiposity Implicates Genes Involved in Immune and Endocrine Systems
RNA Sequencing of Exosomes Revealed Differentially Expressed Long Noncoding RNAs in Early-Stage Esophageal Squamous Cell Carcinoma and Benign Esophagitis
Transcriptome hallmarks in Helicobacter pylori infection influence gastric cancer and MALT lymphoma